Advertisement

Anticoagulants for the Treatment of Transient Ischemic Attacks

  • Fletcher H. McDowell

Abstract

Anticoagulants as a treatment for Transient Ischemic Attacks were originally suggested over 30 years ago. After 30 years of study and many clinical reports covering their use plus several specifically conducted studies to evaluate their effectiveness, there is no unanimity of opinion now whether or not they are a useful treatment for the prevention of recurrent transient ischemic attacks and whether they reduce the possibility of stroke in the future (6, 11, 23, 47).

Keywords

Cerebral Infarction Transient Ischemic Attack Anticoagulant Therapy Basilar Artery Hemorrhagic Complication 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Acheson J, Hutchinson EC: Observations on the natural history of transient cerebral ischemia. Lancet 2:871–874, 1964.PubMedCrossRefGoogle Scholar
  2. 2.
    Baker RN, Broward JA, Fang HC, et al: Anticoagulant therapy in cerebral infarction. Neurol 12:823–835, 1962.CrossRefGoogle Scholar
  3. 3.
    Baker RN, Ramseyer JC, Schwartz WS: Prognosis in patients with cerebral ischemic attacks. Neurol 18:1157–1165, 1968.CrossRefGoogle Scholar
  4. 4.
    Baker RN, Schwartz WS, Rose AS: Transient ischemic attacks. Neurol 16:841–847, 1966.CrossRefGoogle Scholar
  5. 5.
    Bradshaw P, Brennan S: Trial of long-term anticoagulant therapy in the treatment of small stroke associated with a normal carotid angiogram. J Neurol Neurosurg & Psychiatry 38:642–647, 1975.CrossRefGoogle Scholar
  6. 6.
    Browne TR, Poskanzer DC: Treatment of strokes. N Engl J Med 284:594–602, 1969.CrossRefGoogle Scholar
  7. 7.
    Buren A, Ygge J: Treatment program and comparison between anticoagulants and platelet aggregation inhibitors after transient ischemic attack. Stroke 12:578–580, 1981.PubMedCrossRefGoogle Scholar
  8. 8.
    Campbell MH: Basilar artery syndrome. Canad Med Ass J 69:314–315, 1953.PubMedGoogle Scholar
  9. 9.
    Deyken D: Warfarin therapy. N Engl J Med 283:691–694, 1970.CrossRefGoogle Scholar
  10. 10.
    Duncan GW, Pessin MS, Mohr JP, Adams RD: Transient cerebral ischemic attacks. Advances in Internal Medicine 21:1–20, 1976.PubMedGoogle Scholar
  11. 11.
    Easton JD, Byer JA: Transient cerebral ischemic medical management. pp. 41–47. In current concepts in cerebrovascular disease. (eds.) McDowell FH, Sonnenblick EH, Lesch M. Grune & Stratton, New York, 1980.Google Scholar
  12. 12.
    Eriksson SE: Evaluation of anticoagulants in patients with cerebral infarction with slight to moderate neurological deficit. ACTA Neurol Scand 68:96–106, 1983.PubMedCrossRefGoogle Scholar
  13. 13.
    Feiring EH: Spontaneous occlusion of the internal carotid artery. Neurol 4:405–421, 1954.CrossRefGoogle Scholar
  14. 14.
    Fisher CM: Occlusion of the internal carotid artery. Arch Neurol & Psych 65:346–377, 1951.CrossRefGoogle Scholar
  15. 15.
    Fisher CM, Cameron DG: Concerning cerebral vasospasm. Neurol 3:468–473, 1953.CrossRefGoogle Scholar
  16. 16.
    Fisher CM: The use of anticoagulants in cerebral thrombosis. Neurol 8:311–332, 1958.CrossRefGoogle Scholar
  17. 17.
    Fisher CM: Anticoagulant therapy in cerebral thrombosis and cerebral embolism — A national cooperative study, interim report. Neurol 11(4 part 2):119–131, 1961.CrossRefGoogle Scholar
  18. 18.
    Fisher CM: Anticoagulant therapy. pp. 86–89. Third Conference on cerebral vascular diseases. (ed.) Millikan CH, Siekert RG, Whisnant JP. Grune& Stratton, New York, 1961.Google Scholar
  19. 19.
    Frank G: Comparison of antigoagulation and surgical treatments of T.I.A. A review and consolidation of recent natural history and treatment studies. Stroke 2:369–377, 1971.PubMedCrossRefGoogle Scholar
  20. 20.
    Friedman GD, Wilson WS, Mosier JM, et al: Transient ischemic attacks in a community. JAMA 210:1428–1434, 1969.PubMedCrossRefGoogle Scholar
  21. 21.
    Gallhofer B, Ladurner G, Lechner H: Prognosis of prophylactic anticoagulant treatment in ischaemic stroke. Eur Neurol 18:145–148, 1979.PubMedCrossRefGoogle Scholar
  22. 22.
    Garde A, Samuelsson K, Fahlgren H, Hedberg E, Hjerne LG, Ostman J: Treatment after transient ischemic attacks, a comparison between anticoagulant drug and inhibition of platelet aggregation. Stroke 14:677–681, 1983.PubMedCrossRefGoogle Scholar
  23. 23.
    Genton E, Barnett HJM, Fields WS, Gent M, Hoak JC: Cerebral Ischemia: The Role of Thrombosis and of Antithrombotic Therapy. Stroke 8:150–175, 1977.PubMedCrossRefGoogle Scholar
  24. 24.
    Goldner LC, Whisnant JP, Taylor WF: Long Term Prognosis of Transient Cerebral Ischemic Attacks. Stroke 2:160–167, 1971.PubMedCrossRefGoogle Scholar
  25. 25.
    Gowers WR: A Manual of Diseases of the Nervous System. p. 432. Blakiston, Philadelphia, 1893.Google Scholar
  26. 26.
    Gunning AJ, Pickering GW, Robb-Smith AHT, et al: Mural thrombosis of the internal carotid artery and subsequent embolism. Q J Med 33:155–193, 1964.PubMedGoogle Scholar
  27. 27.
    Hill AB, Marshall J. Shaw DA: A controlled clinical trial of long-term anticoagulant therapy in cerebrovascular disease. Q J Med 29:597–609, 1959.Google Scholar
  28. 28.
    Hunt JR: The role of the Carotid Arteries in the Causation of Vascular Lesions of the Brain with Remarks on Special Features of the Symptomology. Am J Med Sci 147:704–713, 1914.CrossRefGoogle Scholar
  29. 29.
    Levine M, Hirsh J: Hemorrhagic Complications of Long Term Anticoagulants Therapy for Ischemic Vascular Disease. Stroke 17:111–116, 1986.PubMedCrossRefGoogle Scholar
  30. 30.
    Link H, Lebram G, Johansson I, Radberg C: Prognosis in patients with infarction and TIA in carotid territory during and after anticoagulant therapy. Stroke 10:529–532, 1979.PubMedCrossRefGoogle Scholar
  31. 31.
    McDowell FH: Transient cerebral ischemic diagnostic considerations. pp. 7–22. In current concepts in cerebrovascular disease. (eds.) McDowell FH, Sonnenblick EH, Lesch M. Grune & Stratton, New York, 1980.Google Scholar
  32. 32.
    Marshall J, Meadows EC: The natural history of amaurosis fugax. Brain 91:419–434, 1968.PubMedCrossRefGoogle Scholar
  33. 33.
    Marshall J, Wilkinson IMS: The prognosis of carotid transient ischaemic attacks in patients with normal angiograms. Brain 94:395–402, 1971.PubMedCrossRefGoogle Scholar
  34. 34.
    Marshall J, Reynolds EH: Withdrawal of anticoagulants from patients with transient ischemic cerebrovascular attacks. Lancet 2:5–6, 1965.CrossRefGoogle Scholar
  35. 35.
    Marshall J: The natural history of transient ischaemic cerebrovascular attacks. Q J Med 33:309–324, 1964.PubMedGoogle Scholar
  36. 36.
    Millikan CH, Whisnant JP: Anticoagulant therapy in cerebro-vascular disease — current status. J Amer Med Ass 166:587–592, 1958.CrossRefGoogle Scholar
  37. 37.
    Millikan CH, Siekert RG, Schick RM: Studies in cerebrovascular disease V. The use of anticoagulant drugs in the treatment of intermittent insufficiency of the internal carotid arterial system. Proc Mayo Clin 30:578–586, 1955.Google Scholar
  38. 38.
    Milliken CH, Siekert RG, Schick RM: Studies in cerebrovascular disease III. The use of anticoagulant drugs in the treatment of insufficiency or thrombosis within the basilar artery system. Proc Mayo Clin 30:116–126, 1955.Google Scholar
  39. 39.
    Millikan CH: Reassessment of Anticoagulant Therapy in Various Types of Occlusive Cerebrovascular Disease. Stroke 2:201–208, 1971.PubMedCrossRefGoogle Scholar
  40. 40.
    Millikan CH: Transient cerebral ischemia definition and natural history. pp. 1–6. In current concepts in cerebrovascular disease. (eds.) McDowell FH, Sonnenblick EH, Lesch M. Grune & Stratton, New York, 1980.Google Scholar
  41. 41.
    Millikan CH, McDowell FH: Treatment of transient ischemic attacks. Stroke 9:299–308, 1978.PubMedCrossRefGoogle Scholar
  42. 42.
    Olsson JE, Muller R, Bernali S: Long-term anticoagulant therapy for T.I.As. and minor strokes with minimum residuum. Stroke 7:444–451, 1976.PubMedCrossRefGoogle Scholar
  43. 43.
    Olsson JE, Brechter C, Backlund H, Krook H, Muller R, Nitelius E, Olsson O, Tornberg A: Anticoagulant vs anti-platelet therapy as prophylactic against cerebral infarction in transient ischemic attacks. Stroke 11:4–9, 1980.PubMedCrossRefGoogle Scholar
  44. 44.
    Pearce JMS, Gabbay SS, Walton J: Long-term anticoagulant therapy in transient cerebral ischemic attacks. Lancet 1:6–9, 1965.PubMedCrossRefGoogle Scholar
  45. 45.
    Ramirez-Lassepass M, Quinones MR: Heparin Therapy for Stroke Hemorrhagic Complications and Risk Factors for Intracerebral Hemorrhage. Neurol 34:114–117, 1984.CrossRefGoogle Scholar
  46. 46.
    Rose WM: Anticoagulants in the management of cerebral infarction: A record of the poor result obtained. Med J Aust 1:503–504, 1950.PubMedGoogle Scholar
  47. 47.
    Siekert RG, Millikan CH, Whisnant JP: Anticoagulant therapy in intermittent cerebrovascular insufficiency. JAMA 176:19–22, 1961.CrossRefGoogle Scholar
  48. 48.
    Siekert RG, Whisnant JP, Millikan CH: Surgical and Anticoagulant Therapy of Occlusive Cerebrovascular Disease. Ann Intern Med 58:637–641, 1963.PubMedCrossRefGoogle Scholar
  49. 49.
    Schmidley JW, Caronna JJ: Transient cerebral ischemic pathophysiology. pp. 23–40. In current concepts in cerebrovascular disease. (eds.) McDowell FH, Sonnenblick EH, Lesch M. Grune & Stratton, New York, 1980.Google Scholar
  50. 50.
    Terent A: The outcome of patients with transient ischemic attacks and stroke treated with anticoagulants. ACTA Med Scand 208:359–365, 1980.PubMedCrossRefGoogle Scholar
  51. 51.
    Toole JF, Janeway R, Choi R, et al: Transient ischemic attacks due to atherosclerosis, a prospective study of 160 patients. Arch Neurol 32:5–13, 1975.PubMedCrossRefGoogle Scholar
  52. 52.
    Veterans Administration Cooperative Study of Atherosclerosis Neurology Section: An Evaluation of Anticoagulant Therapy in the Treatment of Cerebrovascular Disease. Neurol 11:132–138, 1961.CrossRefGoogle Scholar
  53. 53.
    Warlow C: Transient ischaemic attacks, current treatment concepts. Drugs 29:474–482, 1985.PubMedCrossRefGoogle Scholar
  54. 54.
    Weksler BB, Lewin M: Anticoagulation in cerebral ischemia. Stroke 14:658–663, 1983.PubMedCrossRefGoogle Scholar
  55. 55.
    Whisnant JP, Matsumoto N, Elveback LR: The effect of anticoagulant therapy on the prognosis of patients with transient cerebral ischemic attacks in a community. Mayo Clin Proc 48:844–848, 1973.PubMedGoogle Scholar
  56. 56.
    Wilson SA, Bruce AN. (ed.) Neurology, p.1088. Edward Arnold, London, 1940.Google Scholar
  57. 57.
    Ziegler DK, Hassanein RS: Prognosis in patients with transient ischemic attacks. Stroke 4:666–673, 1973.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1987

Authors and Affiliations

  • Fletcher H. McDowell
    • 1
  1. 1.The Burke Rehabilitation CenterWhite PlainsUSA

Personalised recommendations